Bullfrog AI announces expansion of internal sales organization

BullFrog AI (BFRG) Holdings announced the expansion of its internal sales organization to support accelerated commercialization of the Company’s clinical trial optimization offerings, including its recently launched bfPREP module. The expansion of BullFrog AI’s in-house sales capabilities complements the Company’s recent commercial rollout with Sygnature Discovery, which is focused on selling BullFrog Data Networks target selection solutions to global biopharma clients. By strengthening its direct sales organization, BullFrog AI is positioned to accelerate adoption of its trial-focused platforms, including bfPREP, among pharmaceutical and biotechnology companies.